Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Botnar Institute of Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom.
PLoS One. 2020 Apr 2;15(4):e0230235. doi: 10.1371/journal.pone.0230235. eCollection 2020.
Rotator cuff tears are a common cause of shoulder pain and can result in prolonged periods of pain, disability and absence from work. Rotator cuff repair surgery is increasingly used in an attempt to resolve symptoms but has failure rates of around 40%. There is a pressing need to improve the outcome of rotator cuff repairs. Patch augmentation increasingly being used within the NHS in an attempt to reduce repair failures. The aim of this survey was to determine current UK practice and opinion relating to the factors that influence choice of patch, current patient selection and willingness to assist with generation of improved evidence.
An online survey was sent to the surgeon members of the British Elbow and Shoulder Society (BESS). Questions covered respondent demographics, experience with patches, indications for patch augmentation and willingness to be involved in a randomised trial of patch augmented rotator cuff surgery.
The response rate was 105/550 (19%). 58% of respondents had used a patch to augment rotator cuff surgery. 70% of patch users had undertaken an augmented repair within the last 6 months. A wide surgical experience in augmentation was reported (ranging 1 to 200 implants used). However, most surgeons reported low volume usage, with a median of 5 rotator cuff augmentation procedures performed. At least 10 different products had been used. Most of the patches used were constructed from human decellularised dermis tissue, although porcine derived and synthetic based patches had also been used. Only 3-5% stated they would undertake an augmented repair for small tears across ages, whereas 28-40% and 19-59% would do so for large or massive tears respectively. When assessing patient suitability, patient age seemed relevant only for those with large and massive tears. Half of the surgeons reported an interest in taking part in a randomised controlled trial (RCT) evaluating the role of patch augmentation for rotator cuff surgery, with a further 22% of respondent's undecided.
A variety of patches have been used by surgeons to augment rotator cuff repair with a wide range of operator experience. There was substantial uncertainty about which patch to use and differing views on which patients were most suitable. There is a clear need for robust clinical evaluation and further research in this area.
肩袖撕裂是肩部疼痛的常见原因,可导致长时间疼痛、残疾和旷工。肩袖修复手术越来越多地用于尝试解决症状,但失败率约为 40%。迫切需要改善肩袖修复的结果。补片增强术在英国国民保健制度(NHS)中越来越多地被使用,试图降低修复失败率。本调查的目的是确定与补片选择相关的当前英国实践和观点、当前患者选择以及参与生成改进证据的意愿。
向英国肘肩学会(BESS)的外科医生成员发送了在线调查。问题涵盖了受访者的人口统计学、补片使用经验、补片增强的适应症以及参与补片增强肩袖手术随机试验的意愿。
回复率为 105/550(19%)。58%的受访者曾使用补片增强肩袖手术。70%的补片使用者在过去 6 个月内进行了增强修复。报告了广泛的增强手术经验(使用的植入物数量从 1 到 200 个不等)。然而,大多数外科医生报告说使用量低,中位数为 5 例肩袖增强手术。使用了至少 10 种不同的产品。使用的补片大多由人去细胞真皮组织制成,尽管也使用了猪源性和合成基补片。只有 3-5%的人表示他们会为年龄较大的小撕裂进行增强修复,而 28-40%和 19-59%的人分别会为大撕裂或巨大撕裂进行修复。在评估患者的适宜性时,患者年龄似乎仅与大撕裂和巨大撕裂有关。一半的外科医生报告有兴趣参与评估补片增强在肩袖手术中的作用的随机对照试验(RCT),另有 22%的受访者未决定。
外科医生使用了各种补片来增强肩袖修复,手术医生的经验范围广泛。在使用哪种补片以及哪些患者最适合方面存在很大的不确定性。在这一领域需要进行强有力的临床评估和进一步研究。